Total Funding
76
59
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29125
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
- Karl Beutner: Co-Founder, Chief Executive Officer, Chief Medical Officer
- Robert Brucker: Co-Founder, Chief Scientific Officer
About the Company
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases. It is at the intersection of two highly active sectors: dermatology and the microbiome. They harness naturally occurring microbes on the human skin that have evolved over hundreds of thousands of years to compete with pathogenic microbes
(fungi, bacteria, viruses, etc.).
The company was founded in 2017 and is headquartered in Boston, Massachusetts with a satellite office in Emeryville, California.
